Energy transmission and power sources for mechanical circulatory support devices to achieve total implantability.

Left ventricular assist device therapy has radically improved congestive heart failure survival with smaller rotary pumps. The driveline used to power today's left ventricular assist devices, however, continues to be a source of infection, traumatic damage, and rehospitalization. Previous attempts to wirelessly power left ventricular assist devices using transcutaneous energy transfer systems have been limited by restrictions on separation distance and alignment between the transmit and receive coils. Resonant electrical energy transfer allows power delivery at larger distances without compromising safety and efficiency. This review covers the efforts to wirelessly power mechanical circulatory assist devices and the progress made in enhancing their energy sources.

[1]  ヒュプナー・ブルクハルト.  Apparatus for transmitting electrical energy , 2009 .

[2]  Simon C Malpas,et al.  A novel low temperature transcutaneous energy transfer system suitable for high power implantable medical devices: performance and validation in sheep. , 2010, Artificial organs.

[3]  Malin VanAntwerp,et al.  The Artificial Heart: Prototypes, Policies, and Patients , 1992, Annals of Internal Medicine.

[4]  V. S. Mallela,et al.  Trends in Cardiac Pacemaker Batteries , 2004, Indian pacing and electrophysiology journal.

[5]  J. Connell,et al.  Neurologic events with a totally implantable left ventricular assist device: European LionHeart Clinical Utility Baseline Study (CUBS). , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[6]  M. Amrani,et al.  Clinical experience with HeartWare left ventricular assist device in patients with end-stage heart failure. , 2012, The Annals of thoracic surgery.

[7]  K. Butler,et al.  HeartMate left ventricular assist devices: a multigeneration of implanted blood pumps. , 2001, Artificial organs.

[8]  B. Griffith,et al.  Progress on development of the Nimbus-University of Pittsburgh axial flow left ventricular assist system. , 1998, ASAIO journal.

[9]  Itsuro Saito,et al.  Functions For Detecting Malposition of Transcutaneous Energy Transmission Coils , 2003, ASAIO journal.

[10]  Victor Poirier.  Will we see nuclear-powered ventricular assist devices? , 2012, ASAIO journal.

[11]  J. Conte,et al.  Left ventricular assist device driveline infections. , 2011, Cardiology clinics.

[12]  M C Oz,et al.  Long-term use of a left ventricular assist device for end-stage heart failure. , 2001, The New England journal of medicine.

[13]  F. Pagani,et al.  Continuous-flow devices and percutaneous site infections: clinical outcomes. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[14]  Alanson P. Sample,et al.  Powering a Ventricular Assist Device (VAD) With the Free-Range Resonant Electrical Energy Delivery (FREE-D) System , 2012, Proceedings of the IEEE.

[15]  S. Furukawa,et al.  Infections associated with ventricular assist devices: epidemiology and effect on prognosis after transplantation , 2005, Transplant infectious disease : an official journal of the Transplantation Society.

[16]  Dennis R Trumble,et al.  In Vivo Performance of a Muscle-Powered Drive System for Implantable Blood Pumps , 2008, ASAIO journal.

[17]  Roland Hetzer,et al.  Does total implantability reduce infection with the use of a left ventricular assist device? The LionHeart experience in Europe. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[18]  A Solar Cell System for Extension of Battery Run Time in a Moving Actuator Total Artificial Heart , 1997, ASAIO journal.

[19]  Javed Butler,et al.  Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial. , 2007, Journal of the American College of Cardiology.

[20]  Vakhtang Tchantchaleishvili,et al.  Plutonium-238: An Ideal Power Source for Intracorporeal Ventricular Assist Devices? , 2012, ASAIO journal.

[21]  D J Burke,et al.  The Heartmate II: design and development of a fully sealed axial flow left ventricular assist system. , 2001, Artificial organs.

[22]  Alanson P. Sample,et al.  Analysis , Experimental Results , and Range Adaptation of Magnetically Coupled Resonators for Wireless Power Transfer , 2010 .

[23]  Fouche Aa.  John H. Gibbon. The first 20 years of the heart-lung machine. , 1997 .

[24]  G Rosenberg,et al.  The LionHeart LVD-2000: a completely implanted left ventricular assist device for chronic circulatory support. , 2001, The Annals of thoracic surgery.

[25]  Michiel Morshuis,et al.  Preliminary experience with the LionHeart left ventricular assist device in patients with end-stage heart failure. , 2003, The Annals of thoracic surgery.

[26]  Martin Cadeiras,et al.  Device Related Infections: Are We Making Progress? , 2010, Journal of cardiac surgery.

[27]  G M Pantalos,et al.  Artificial heart: past, present, and future. , 1993, Artificial organs.

[28]  M. Soljačić,et al.  Efficient wireless non-radiative mid-range energy transfer , 2006, physics/0611063.

[29]  M. T. Byrne,et al.  Improved mechanism for capturing muscle power for circulatory support. , 2003, Artificial organs.

[30]  Nader Moazami,et al.  Late-onset driveline infections: the Achilles' heel of prolonged left ventricular assist device support. , 2007, The Annals of thoracic surgery.

[31]  Thomas C Rintoul,et al.  Thoratec Transcutaneous Energy Transformer System: A Review and Update , 2004, ASAIO journal.

[32]  L. Miller,et al.  Mechanical circulatory support : a companion to Braunwald's heart disease , 2012 .

[33]  O H Frazier,et al.  Surgery for Acquired Cardiovascular Disease Initial experience with the AbioCor Implantable Replacement Heart System , 2004 .

[34]  Deborah Budge,et al.  Obesity and Left Ventricular Assist Device Driveline Exit Site Infection , 2010, ASAIO journal.

[35]  Walter R Wilson,et al.  Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. , 2010, Circulation.

[36]  H. E. Stephenson,et al.  Energy transfer into a closed chest by means of stationary coupling coils and a portable high-power oscillator. , 1961, Transactions - American Society for Artificial Internal Organs.

[37]  Mark S Slaughter,et al.  Transcutaneous Energy Transmission for Mechanical Circulatory Support Systems: History, Current Status, and Future Prospects , 2010, Journal of cardiac surgery.

[38]  M Szycher,et al.  Thermedics' Approach to Ventricular Support Systems , 1986, Journal of biomaterials applications.

[39]  M. Vanantwerp,et al.  The Artificial Heart Program: Current Status and History , 1991 .

[40]  F. Lowy,et al.  Ventricular assist device-related infections. , 2006, The Lancet. Infectious diseases.

[41]  S. Kurtz,et al.  Infection burden for hip and knee arthroplasty in the United States. , 2008, The Journal of arthroplasty.

[42]  R. Morris,et al.  Total artificial heart--concepts and clinical use. , 2008, Seminars in thoracic and cardiovascular surgery.

[43]  A New Universal Wireless Transcutaneous Energy Transfer (TET) System for Implantable LVADs – Preliminary In Vitro and In Vivo Results , 2013 .

[44]  W. A. Adams,et al.  Comparison of rechargeable lithium and nickel/cadmium battery cells for implantable circulatory support devices. , 1994, Artificial organs.

[45]  Otto J. Adlhart,et al.  A Small Portable Proton Exchange Membrane Fuel Cell and Hydrogen Generator for Medical Applications , 1997, ASAIO journal.

[46]  Joseph E Marine,et al.  50th Anniversary of the first successful permanent pacemaker implantation in the United States: historical review and future directions. , 2010, The American journal of cardiology.